Rising prevalence of infectious diseases, increasing focus on drug discovery, and growing demand of protein therapeutics are some key factors expected to drive market growth
According to Emergen Research, the global antibody services market size was USD 1.41 Billion in 2020 and is expected to reach USD 3.30 Billion in 2028 and register a revenue CAGR of 11.1% during the forecast period, 2021-2028.
Biological products such as antibodies are in high demand for both academic research as well as pharmaceutical research. Multiple steps are involved in developing antibodies, such as antigen design, hybridoma generation, animal immunization, and protein purification. To ensure the quality of antibody, screenings and assays are necessary between each step. Antibodies are useful for quantifying, detecting, delivering cargos (for instance, small drugs), and activating specific protein interactions. Recombinant antibody platforms are extremely adaptable, and provide a scalable supply of antibodies that has proven to be extremely useful in diagnostics, research, and therapeutic applications. Sequence-specific antibodies are invaluable to support characterization studies of anti-sense drugs, also known as Anti-Sense Oligonucleotides (ASOs). Therefore, increasing awareness regarding benefits of antibodies in R&D activities for drug development is a major factor expected to drive market revenue growth during the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/632
In addition, increasing development of immunodiagnostics or immunotherapies, rising demand for protein therapeutics, and rising investment in drug discovery by clinical research organizations and government are some major factors expected to positively impact revenue growth of the market. However, high capital investments and production, and stringent government regulations, and high cost of antibody production are some factors expected to restrain market growth to a certain extent over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Monoclonal Segment Revenue to Expand at a Rapid CAGR:
Monoclonal segment is expected to register a rapid revenue CAGR over the forecast period attributed to increasing investment in monoclonal antibody research and large scale commercialization of antibody based products. In addition, monoclonal antibody drugs are used in cancer treatments as they use natural immune system functions to combat cancer.
Check Our Prices@ https://www.emergenresearch.com/select-license/632
BioScience Companies Segment to Register Significant Revenue Growth:
BioScience companies segment is expected to register significant revenue growth over the forecast period due to rising government investment in biotech companies for introduction of new and effective drugs and ongoing large number of drug development procedures during COVID-19 pandemic.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to rapid development in healthcare sector, rising focus on drug delivery services, and favorable government policies on therapeutic antibodies. Further, growing number of biotech companies in the region and increasing number of patients suffering from infectious diseases are some other factors expected to contribute to market growth in the region.
Major Companies in the Market Include:
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corporation
- Sigma-Aldrich Corporation
- Eppendorf AG
- Cellab GmbH
- INTEGRA Biosciences AG
- FiberCell Systems Inc.
For the purpose of this report, Emergen Research has segmented the global antibody services market based on service, type, end-use, and region:
Service Outlook (Revenue, USD Billion; 2018–2028)
- Antibody Development
- Antigen Preparation
- Immunization & Hybridoma Production
- Antibody Characterization
- Antibody Production & Purification
- Antibody Fragmentation & Labeling
Type Outlook (Revenue, USD Billion; 2018–2028)
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- BioScience Companies
- BioScience Research Institutions
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/antibody-services-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Take a Look at our Related Reports:
Forensic Technology Market By Type (Polymerase Chain Reaction, Capillary Electrophoresis, Next Generation Sequencing, Rapid DNA Analysis, Automated Liquid Handling Technology, Microarrays), By Application (Healthcare, Law Enforcement Agencies, Banking & Financial Institutions, Telecom) and By Regions Forecasts to 2027
Metastatic Cancer Treatment Market By Treatment Type, By Application, By End-Users, Forecasts to 2027
Anti-Aging Devices Market By Device Type, By Product Type, By Application, Forecasts to 2027
Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027
Tissue Imaging Market By Technology, By Products, By Application, By End-Users, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-antibody-services-market